Immune cell types and levels have long been linked to cancer outcomes [77]; high levels of specific immune cell types (e.g., CD8+ T cells, NK cells) within the tumour microenvironment (TME) are generally linked to a higher probability of remaining cancer-free after surgery and longer overall survival [78, 79]. Here, CD8A is linked to neoplasm.